Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord
- 24 July 2009
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 877 (27) , 3065-3071
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Meconium Nicotine and Metabolites by Liquid Chromatography-Tandem Mass Spectrometry: Differentiation of Passive and Nonexposure and Correlation with Neonatal Outcome MeasuresClinical Chemistry, 2008
- Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium With Neonatal OutcomesClinical Pharmacology & Therapeutics, 2008
- The effects of prenatal cocaine use on infant developmentNeurotoxicology and Teratology, 2008
- Biological Matrices for the Evaluation of In Utero Exposure to Drugs of AbuseTherapeutic Drug Monitoring, 2007
- Using population data to examine the prevalence and correlates of neonatal abstinence syndromeDrug and Alcohol Review, 2007
- Bioanalytical procedures for monitoring in utero drug exposureAnalytical and Bioanalytical Chemistry, 2007
- Drug abuse’s smallest victims: in utero drug exposureForensic Science International, 2002
- Mortality Within the First 2 Years in Infants Exposed to Cocaine, Opiate, or Cannabinoid During GestationPediatrics, 1997
- The effects of prenatal cocaine use on neonatal neurobehavioral statusNeurotoxicology and Teratology, 1996
- Treatment Issues for Opioid-Dependent Women During the Perinatal PeriodJournal of Psychoactive Drugs, 1991